Abstract:PURPOSE: It is of great significance to accurately identify the KRAS gene mutation status for patients in tumor prognosis and personalized treatment. Although the computer-aided diagnosis system based on deep learning has gotten all-round development, its performance still cannot meet the current clinical application requirements due to the inherent limitations of small-scale medical image data set and inaccurate lesion feature extraction. Therefore, our aim is to propose a deep learning model based on T2 MRI of colorectal cancer (CRC) patients to identify whether KRAS gene is mutated.METHODS: In this research, a multitask attentive model is proposed to identify KRAS gene mutations in patients, which is mainly composed of a segmentation subnetwork and an identification subnetwork. Specifically, at first, the features extracted by the encoder of segmentation model are used as guidance information to guide the two attention modules in the identification network for precise activation of the lesion area. Then the original image of the lesion and the segmentation result are concatenated for feature extraction. Finally, features extracted from the second step are combined with features activated by the attention modules to identify the gene mutation status. In this process, we introduce the interlayer loss function to encourage the similarity of the two subnetwork parameters and ensure that the key features are fully extracted to alleviate the overfitting problem caused by small data set to some extent.RESULTS: The proposed identification model is benchmarked primarily using 15-fold cross validation. Three hundred and eighty-two images from 36 clinical cases were used to test the model. For the identification of KRAS mutation status, the average accuracy is 89.95 <math><mo>±</mo></math> 1.23%, the average sensitivity is 89.29 <math><mo>±</mo></math> 1.79%, the average specificity is 90.53 <math><mo>±</mo></math> 2.45%, and the average area under the curve (AUC) is 95.73 <math><mo>±</mo></math> 0.52%. For segmentation of lesions, the average dice is 88.11 <math><mo>±</mo></math> 0.86%.CONCLUSIONS: We developed a novel deep learning-based model to identify the KRAS status in CRC. We demonstrated the excellent properties of the proposed identification through comparison with ground truth gene mutation status of 36 clinical cases. And all these results show that the novel method has great potential for clinical application.

Spatial-Frequency Dual-Branch Attention Model For Determining Kras Mutation Status In Colorectal Cancer With T2-Weighted Mri

Multi-branch Cross Attention Model for Prediction of KRAS Mutation in Rectal Cancer with T2-Weighted MRI

A Multi-Task Dual-Stream Attention Network for the Identification of KRAS Mutation in Colorectal Cancer.

A multitask dual‐stream attention network for the identification of KRAS mutation in colorectal cancer

Integrating image and gene-data with a semi-supervised attention model for prediction of KRAS gene mutation status in non-small cell lung cancer

A Segmentation-Based Sequence Residual Attention Model for KRAS Gene Mutation Status Prediction in Colorectal Cancer

Segmentation-based Multi-Scale Attention Model for KRAS Mutation Prediction in Rectal Cancer

KRAS mutation status between left- and right-sided colorectal cancer: are there any differences in computed tomography?

A Deep Learning Model Based on MRI and Clinical Factors Facilitates Noninvasive Evaluation of KRAS Mutation in Rectal Cancer

Noninvasive KRAS mutation estimation in colorectal cancer using a deep learning method based on routine CT imaging

Noninvasive KRAS mutation estimation in colorectal cancer using a deep learning method based on CT imaging

KRASFormer: a fully vision transformer-based framework for predicting KRAS gene mutations in histopathological images of colorectal cancer

A Disentangled Representation-Based Multimodal Fusion Framework Integrating Pathomics and Radiomics for KRAS Mutation Detection in Colorectal Cancer

SG-Transunet: A segmentation-guided Transformer U-Net model for KRAS gene mutation status identification in colorectal cancer

Feasibility of MRI Radiomics for Predicting KRAS Mutation in Rectal Cancer

Deep neural network for the prediction of KRAS, NRAS, and BRAF genotypes in left-sided colorectal cancer based on histopathologic images

Development and Validation of Radiomics Signatures to Predict KRAS Mutation Status Based on Triphasic Enhanced Computed Tomography in Patients with Colorectal Cancer

MRI Radiomics Signature as a Potential Biomarker for Predicting KRAS Status in Locally Advanced Rectal Cancer Patients

Development and Validation of a MRI-based Radiomics Signature for Prediction of KRAS Mutation in Rectal Cancer

Predicting Kirsten Rat Sarcoma Virus Gene Mutation Status in Patients With Colorectal Cancer by Radiomics Models Based on Multiphasic CT

ALA-Net: Adaptive Lesion-Aware Attention Network for 3D Colorectal Tumor Segmentation